AI Science Tracker
EN

Pathomics-based machine learning models for predicting METTL5 expression and prognosis in lung adenocarcinoma.

Department of Pathology · 28 Aug 2026 · medicine

Discovery

Pathomics-based machine learning models for predicting METTL5 expression and prognosis in lung adenocarcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The primary full text supports the case-specific result: Pathomics models predicted METTL5 expression and prognosis in lung adenocarcinoma with validation performance.

Technology: Methods identify the case-specific learned operation: Pathomics models predicted METTL5 expression and prognosis in lung adenocarcinoma with validation performance.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods identify the case-specific learned operation: Pathomics models predicted METTL5 expression and prognosis in lung adenocarcinoma with validation performance.
Limitation / still unknown
The full text reports the case-specific data/cohort, comparison/reference and evaluation; no broader clinical benefit is inferred.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13559335/ · https://pubmed.ncbi.nlm.nih.gov/42724470/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.